This entry was posted on July 30, 2009 at 8:20 am and is filed under Astra, pi3k.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
AstarZeneca has had PIK3beta for some time. AZD-6482 commenced phase I studies, for thrombosis, in January 2008. It’s still in phase I according to the 30 July 2009 update.
Journals (beta)
=CN(C2=NC(N3CCOCC3)=C4)C4=O)C](https://kinasepro.files.wordpress.com/2009/07/az-pi3k-structure.jpg?w=220&h=227 "az-pi3k-structure")
petros said
AstarZeneca has had PIK3beta for some time. AZD-6482 commenced phase I studies, for thrombosis, in January 2008. It’s still in phase I according to the 30 July 2009 update.
kinasepro said
Awesome, thanks
Jay said
Does anybody know of any publications with this compound? Is it commercially available from any small companies?
J